APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 66 filers reported holding APTINYX INC in Q2 2021. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,028,000 | +14.1% | 1,883,244 | 0.0% | 0.39% | +9.6% |
| Q3 2021 | $4,407,000 | -17.3% | 1,883,244 | 0.0% | 0.35% | -28.3% |
| Q2 2021 | $5,330,000 | -44.3% | 1,883,244 | -41.0% | 0.49% | -35.9% |
| Q1 2021 | $9,570,000 | -13.3% | 3,190,079 | 0.0% | 0.77% | -9.6% |
| Q4 2020 | $11,038,000 | +2.4% | 3,190,079 | 0.0% | 0.85% | -12.2% |
| Q3 2020 | $10,782,000 | -19.0% | 3,190,079 | 0.0% | 0.97% | -17.1% |
| Q2 2020 | $13,303,000 | +93.0% | 3,190,079 | 0.0% | 1.17% | +49.6% |
| Q1 2020 | $6,891,000 | -36.8% | 3,190,079 | 0.0% | 0.78% | -57.3% |
| Q4 2019 | $10,910,000 | -2.0% | 3,190,079 | 0.0% | 1.83% | -47.4% |
| Q3 2019 | $11,133,000 | +4.5% | 3,190,079 | 0.0% | 3.48% | +27.5% |
| Q2 2019 | $10,655,000 | -17.5% | 3,190,079 | 0.0% | 2.73% | -12.2% |
| Q1 2019 | $12,920,000 | -75.5% | 3,190,079 | 0.0% | 3.11% | -77.2% |
| Q4 2018 | $52,764,000 | -42.9% | 3,190,079 | 0.0% | 13.61% | -19.5% |
| Q3 2018 | $92,385,000 | +19.8% | 3,190,079 | 0.0% | 16.92% | +5.9% |
| Q2 2018 | $77,104,000 | – | 3,190,079 | – | 15.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 5,395,996 | $1,997,000 | 0.55% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $3,273,000 | 0.39% |
| Artal Group S.A. | 6,116,493 | $2,251,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $693,000 | 0.05% |
| NORTHWESTERN UNIVERSITY | 109,280 | $40,000 | 0.04% |
| RA Capital Management | 1,954,698 | $720,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $71,000 | 0.01% |
| HBK Sorce Advisory LLC | 26,000 | $26,000 | 0.00% |
| Point72 Asset Management, L.P. | 410,416 | $151,000 | 0.00% |
| Virtu Financial LLC | 23,806 | $9,000 | 0.00% |